CLINICAL_TRIALS
trial_result
· 2025-12-12
Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Syndrome [Phase 2]
Summary
The Phase 2 trial evaluating Basmisanil in children with Dup15q Syndrome was terminated. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Dup15q Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2025-12-12